Site Map

CMV retinitis

Cytomegalovirus retinitis

Cytomegalovirus (CMV) retinitis is a viral infection of the retina of the eye resulting in inflammation.

Images

I Would Like to Learn About:

Causes

CMV retinitis is caused by a member of a group of herpes-type viruses. Infection with CMV is very common. Most people are exposed to CMV in their lifetime, but typically only those with weakened immune systems become ill from CMV infection.

Serious CMV infections can occur in people who have weakened immune systems as a result of:

• HIV/AIDS
• Bone marrow transplant
• Chemotherapy
• Drugs that suppress the immune system
• Organ transplant

Symptoms

Some people with CMV retinitis have no symptoms.

If there are symptoms, they may include:

• Blind spots
• Blurred vision and other vision problems
• Floaters

Retinitis usually begins in one eye, but often progresses to the other eye. Without treatment, damage to the retina can lead to blindness in 4 to 6 months or less.

Exams and Tests

CMV retinitis is diagnosed through an ophthalmologic exam. Dilation of the pupils and ophthalmoscopy will show signs of CMV retinitis.

CMV infection may be diagnosed with blood or urine tests that look for substances specific to the infection. However, an infection may be present even with a negative blood or urine test. CMV can affect specific organs, such as the retina or gastrointestinal (GI) tract, and blood and urine tests can be negative. A tissue biopsy can detect the viral infection and presence of CMV virus particles, but this may be done only for some organs (GI Tract) and not others (eyes).

Treatment

The goal of treatment is to stop the virus from replicating and to stabilize or restore vision and prevent blindness. Long-term treatment is often needed. Medicines may be given by mouth (orally), through a vein (intravenously), or injected directly into the eye (intravitreously).

Outlook (Prognosis)

Even with treatment, the disease can worsen to blindness. This progression may happen because the virus becomes resistant to the antiviral drugs so the drugs are no longer effective, or because the person's immune system has deteriorated further.

CMV retinitis may also lead to retinal detachment, in which the retina detaches from the back of the eye, causing blindness.

Possible Complications

Complications that may result include:

• Kidney impairment (from medicines used to treat the condition)
• Low white blood cell count (from medicines used to treat the condition)

When to Contact a Medical Professional

If symptoms worsen or do not improve with treatment, or if new symptoms develop, contact your health care provider.

People with HIV/AIDS (especially those with a very low CD4 count) who have vision problems should make an appointment right away for an eye exam.

Prevention

A CMV infection usually only causes symptoms in people with a weakened immune system. Certain medicines (such as cancer therapy) and diseases (such as HIV/AIDS) can cause a weakened immune system.

People with AIDS who have a CD4 count of less than 250 cells/microliter or 250 cells/cubic millimeter should be examined regularly for this condition, even if they do not have symptoms. If you had CMV retinitis in the past, ask your provider if you need treatment to prevent its return.

Related Information

Antibody
Immune response
HIV/AIDS
Systemic
Retinal detachment
WBC count

References

Britt WJ. Cytomegalovirus. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Philadelphia, PA: Elsevier; 2020:chap 137.

Freund KB, Sarraf D, Mieler WF, Yannuzzi LA. Infection. In: Freund KB, Sarraf D, Mieler WF, Yannuzzi LA, eds. The Retinal Atlas. 2nd ed. Philadelphia, PA: Elsevier; 2017:chap 5.

BACK TO TOP

Review Date: 11/23/2021  

Reviewed By: Jatin M. Vyas, MD, PhD, Associate Professor in Medicine, Harvard Medical School; Associate in Medicine, Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, MA. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

Health Content Provider 06/01/2025

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complied with the HONcode standard for trustworthy health information from 1995 to 2022, after which HON (Health On the Net, a not-for-profit organization that promoted transparent and reliable health information online) was discontinued.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2024 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.